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1. Introduction
The female genital tract is a complex and physiologically dynamic system of organs which
undergo  continuous  and  profound  changes  during  the  reproductive  years.  Each  of  its
components – ovaries, fallopian tubes and uterus - has unique and indispensable roles in
reproduction. Each month, under stimulation from the pituitary gland, the ovaries produce
and release a mature oocyte,  which moves into the neighboring fallopian tube.  Concep‐
tion takes place in the lumen of the tube and the mucosal epithelium lining plays a critical
part in the transport of the gametes and the successful transfer of the zygote to the uterus,
where it  implants  6-12 days after  fertilization.  Considering the importance of  successful
reproduction for species survival, there is strong evolutionary pressure to make the process
robust and to respond quickly to any cellular damage with effective repair mechanisms.
Also, the inner layer of the uterus, the endometrium, is subjected to monthly shedding and
regeneration  in  order  to  sustain  a  suitable  environment  for  implantation  of  a  potential
embryo. Similar to other tissues like intestine and hair, which continue to undergo rapid
cellular turnover throughout adult life, there is an increasing number of studies describ‐
ing the existence of adult stem cells in the genital tract that ensure tissue renewal through‐
out life.
Historically,  adult stem cells have been described in vivo as rare,  slow-cycling cells that
maintain self-renewal  by asymmetric  division and can differentiate  into different  proge‐
nies. The traditional method of identification has been BrdU labeling, and designated stem
cells have been described as label retaining cells (LRC), although there has been some doubt
concerning the accuracy of the underlying premise that stem cells efficiently incorporate
BrdU [1]. Since BrdU is a mutagen and toxic, this prevents successful recovery and in vitro
analysis  of  labeled cells.  However,  both  old  and new experimental  approaches  recently
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confirmed the existence of  adult  stem cells  in the female reproductive system using the
mouse model system with BrdU pulse labeling [2,3],  as well  as with transgenic animals
with fluorescently labeled histone 2B [4], although it is not yet clear if the two methods do
in fact label the same cells.
Deregulation of the adult stem cell niche, which is the main custodian of homeostasis in
healthy tissues, is considered a potentially significant step in the etiology of cancer as well
as other proliferative disorders, such as endometriosis.  Therefore, basic research into the
biology of adult stem cells is a new and promising field in the search for novel therapeu‐
tic  strategies  for  these  diseases.  This  chapter  will  provide  an  overview  of  the  current
understanding  of  adult  stem  cell  niches  in  the  female  genital  tract,  and  how  new  evi‐
dence regarding its molecular regulation changes our perspective of analyzing and treating
some of its most common pathologies: endometriosis as well as endometrial and ovarian
cancer.  Based on the available evidence,  it  is  safe to conclude that the female reproduc‐
tive tract  harbors adult  stem cells.  However,  in contrast  to an already very comprehen‐
sive and detailed insight into the structure and regulation of the adult stem cell niche in
the gastro-intestinal tract, hair follicle or hematopoetic tissue, details of the niche organiza‐
tion in the genital tract mucosa remain at best sketchy. Experimental data on adult stem
cells  from the genital  tract  almost exclusively originate from in vitro studies of  primary
culture  isolates  and  so-called  "functional  assays"  describing  clonality  assays,  sphere
formation and differentiation capacity for the small population of presumptive stem cell
candidates.  Still,  many  questions  remain  unanswered  regarding  the  molecular  mecha‐
nisms  of  epithelial  renewal  in  a  system  which  during  the  average  reproductive  period
undergoes more than 400 cycles of phenotypical changes in response to shifts in hormo‐
nal stimulation. Of particular importance is the relationship between adult stem cells in the
healthy  tissue  and  so-called  cancer  stem cells  and  we  will  address  the  most  important
developments in this area of research.
We will also briefly review contentious recent evidence for a putative reserve of germline
stem cells (GSCs) in the ovary, which would represent a further population of adult stem
cells,  akin  to  spermatogonia  in  men.  One  of  the  pillars  of  reproductive  medicine  and
infertility treatments is the dogma that women are born with all potential oocytes in place,
arrested in the first  meiotic  prophase.  Thus,  the available "ovarian reserve" is  a limiting
factor in infertility treatments, and egg donation remains the only option for patients who
show  diminished  parameters  for  remaining  primordial  follicles.  Following  on  from  the
postulation that somatic, mitotically active cells in Drosophila melanogaster can act as GSCs
[5] several groups have provided evidence for the existence of GSCs in mouse [6,7] as well
as  human  ovaries  [8].  However,  they  are  yet  to  find  final  acceptance  in  the  scientific
community. If they do indeed exist, they would without doubt revolutionize the field of
reproductive medicine.
Before we review the current “state of the art” of adult stem cell research in the female genital
tract, it is useful to summarize its basic anatomy and histopathology in order to understand
the environment in which stem cells function.
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2. Anatomy and histopathology of cervix, uterine endometrium and
fallopian tube and ovary
Distinct portions of the mucosa along the tract are morphologically and functionally special‐
ized to facilitate the successful completion of the reproductive process: from the oocyte
maturation (ovary) through the transport of gametes (fallopian tube) to the implantation of
the embryo in the endometrium and establishment of a viable pregnancy (uterus). The ovarian
surface epithelium (OSE) is built of simple, flat, cuboidal cells, without mature adhesion
junctions or prominent polarity (Fig. 1A).
Figure 1. Overview of the histology of the female genital tract
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The stroma of the ovary is filled with luteinized stromal cells, decidual cells, neuroendocrine
cells, fat and muscle cells and a population of endometrial-like stromal cells. In addition, the
ovary contains the pool of primordial follicles, which consist of immature primary oocytes,
arrested at birth in the prophase of meiosis 1, surrounded by a densely packed shell of somatic
granulosa cells, which are of key importance for successful growth and maturation of the
ovum. The developing oocyte and neighboring granulosa cells represent a perfect example of
the “niche” where cell-cell interaction and signaling from surrounding tissue compartments
determine cell fate and differentiation (Fig. 1B). The process of ovulation, or specifically
follicule rupture, creates a pro-inflammatory environment high in reactive oxygen species [9,
10], that requires extensive repair mechanisms and tissue remodeling to avoid permanent
damage to the ovary. Indeed OSE cells, though simple in their cellular phenotype, are uniquely
adapted to not only respond to stress conditions, but also to actively participate in the tissue
breakdown and remodeling that enables rupture of the follicle through the ovarian surface
[11]. They express proteolytic enzymes such are metalloprotease 2 and 9 [12], and can undergo
epithelial mesenchymal transition (EMT) [13], which may facilitate efficient repair of the
injured ovarian surface during the post-ovulatory phase of the menstrual cycle. The ovaries
also produce hormones that control the cellular changes associated with the menstrual cycle.
The granulosa cells of growing follicles secrete exponentially increasing amounts of estradiol
and progesterone. After oocyte release, the remaining follicular cells undergo transformation
into the corpus luteum, which immediately starts producing progesterone under the control
of pituitary LH pulses. These two main phases of the menstrual cycle – estradiol-driven
follicular phase and progesterone-driven luteal phase – determine cyclical homeostasis of all
mucosal surfaces in the lower genital tract including fallopian tube, uterus and cervix.
The fallopian tube, or salpinx, is ~ 10 cm long and anatomically divided into three segments:
the isthmus, which connects to the uterus, the ampulla, which constitutes the middle part, and
the infundibulum, proximal to the ovary. The infundibulum terminates in relatively large
opening, the ostium, which has many fine projections, or fimbriae, that capture the oocyte
upon follicule rupture and guide it towards the ampulla, where fertilization takes place. The
histology of the tube, starkly different from the ovarian surface, is characterized by the
presence of an epithelial monolayer of highly differentiated columnar cells with two distinct
cell types: secretory – producing tubular fluid – and ciliated – enabling transport along the
lumen (Fig. 1A). Numerous mucosal folds in the distal and ampullar regions provide a suitable
environment for the early stages of blastocyst development. Contractility of the tube is ensured
by the muscular layer surrounding the epithelium. Although, unlike uterine endometrium,
fallopian epithelium does not undergo extensive monthly shedding, it responds to the
follicular phase hormonal environment by proliferation [14]. Changes in homeostasis are
supported by global gene expression data from fallopian tube mucosal samples, which show
marked differences between follicular and luteal phase [15]. The tubal epithelium is also
exposed to the pro-inflammatory environment associated with ovulation, leading for instance
to an increase in double stranded DNA breaks marked by phospho-γH2A.X in a mouse model
in vivo [16]. Exposing human fallopian tube isolates to follicular fluid ex vivo increases
expression of inflammation-related genes and DNA repair components [17]. In particular,
there is a noticeable accumulation of p53 it the nuclei of tubal cells, which is thought to be a
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key step in the development of premalignant lesions. As well as the potentially genotoxic
effects of follicular fluid, their connection to the uterus also renders the fallopian tubes
vulnerable to ascending infections by sexually transmitted pathogens. Chlamydia trachomatis
and Neisseria gonorrhea are major causes of the inflammatory disease salpingitis, which is
marked by scarring and tissue injury and dramatically increases the risk for tubal occlusion
and infertility. In addition, there is increasing evidence that at least some STDs may also have
a pro-malignant effect on host cells [18-20].
The uterus is a muscular organ with great capacity for growth and physiological transforma‐
tion, which is necessary to support pregnancy. It consists of three layers: the outer serosal layer,
or perimetrium, the myometrium, which contributes the most to the volume and mass of the
organ, and the inner mucosal layer, or endometrium, which is vital for the initiation of
pregnancy. The structure of the endometrial layer has traditionally been divided into the
stratum basalis and the stratum functionalis, which is subjected to monthly cyclical renewal,
differentiation and shedding. The stratum functionalis changes greatly during each menstrual
cycle and is further divided into stratum compactum and stratum spongiosum. The stratum
functionalis consists of glandular epithelium (Fig. 1C) residing on the supportive connective
tissue and blood vessels which supply nutrients. It is at its thinnest at the beginning of the
follicular phase, and proliferates strongly under stimulation by estradiol. The estradiol peak
coincides with the maximum follicle diameter prior to ovulation and with maximal thickness
of the proliferative endometrium. Following ovulation, rising progesterone levels, trigger
differentiation of the stratum functionalis into “secretory” endometrium. At the cellular level,
endometrial glands, which resemble narrow straight tubes during the follicular phase, begin
to swell as progesterone stimulates the columnar epithelial cells to produce and secrete
glycogen granules. It is assumed that this glycogen-rich environment serves as an energy depot
for the implanting blastocyst. In addition, stromal cells undergo a profound change, converting
from a fibroblast-like phenotype into rounded cells that produce prolactin and insulin growth
factor binding protein [21,22]. This complex transformation of the functional layer of the
endometrium, called decidualization, is a prerequisite for successful attachment and invasion
of the trophoblast and thereby initiation of the pregnancy. Progesterone secretion by the corpus
luteum is limited to around two weeks, after which it disintegrates if no chorionic gonadotro‐
pin from an implanted embryo is present in the circulation to rescue its function. In the absence
of progesterone, the endometrial stratum functionalis, epithelium and supportive connective
tissue is shed and expelled by menstrual bleeding.
The uterus is separated from the vaginal canal by the narrow muscular cervix. Due to its
physiological elasticity, the cervix tightens under the influence of progesterone, and essentially
seals the uterus from the outside environment during the second part of the cycle. This
protective barrier is enhanced in the case of pregnancy by the formation of a mucus plug that
fills the endocervical canal. The entrance to the cervix is called external orifice of the uterus,
or external os. The endocervix is lined by simple columnar epithelium, with a similar structure
to the endometrial monolayer, while the outer part is lined by stratified squamous epithelium.
The segment in between – the squamo-columnar junction (SCJ) – is a dynamic zone, which
does not have a fixed location but migrates under the influence of major hormonal changes,
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such as puberty, pregnancy and menopause. Prior to puberty, squamous epithelium covers
the outer segment of the cervix and the lower part of the canal. During puberty and first
pregnancy, the columnar epithelium of the endocervix expands and covers the outer rim of
the external os. Through contact with the low pH of the vagina, the columnar epithelium
undergoes metaplasia over time and converts back towards a squamous phenotype (squamous
metaplasia). It is widely accepted that over 90% of malignancies of the cervix originate from
cellular changes which are initiated in this region of intense tissue remodeling-thus the SCJ is
frequently labelled “transformation zone” (TZ).
3. Putative female GSCs
Before devoting our attention to the somatic adult stem cells of the female genital tract, we will
review the rather contentions field of presumptive GSCs in the adult ovary. Since the 1950s,
the accepted dogma in reproductive biology has been that in mammals primordial germ cell
(PGC)-derived oogonia cease proliferation shortly after birth and differentiate into primary
oocytes, which arrest in prophase of meiosis I until fertilization triggers the completion of
meiosis [23]. As a consequence, the pool of available oocytes is finite – and exhaustion of the
pool of resulting follicles is believed to be responsible for menopause. In the last decade,
however, this assumption has been challenged by a series of papers reporting the existence of
GSCs in the ovaries of mice and humans. First hints came from observations by Tilly’s group
[6], who tried to assess the dynamics of germ cell loss during adult life. Their estimation that
up to a third of immature follicles in mice are degenerating at any given time led them to
postulate that this unexpectedly high rate is incompatible with the slow rate of decline
observed in the follicle reserve. In trying to resolve this contradiction, they identified cells on
the ovarian surface of young mice that express the meiotic entry marker SCP3, as well as BrdU-
incorporating cells that simultaneously express the germ cell marker Ddx4, suggesting that
these cells may be proliferating GSCs responsible for replenishing the follicle pool.
Further evidence for ovarian GSCs that are capable of proliferation followed by differentiation
into oocytes came from the observation that immunomagnetically isolated Ddx4+ cells from
both mouse and human ovaries can be expanded in vitro and give rise to oocytes following
transplantation into donor ovarian tissue [7,8]. In the mouse, GFP-labelled putative
Ddx4+GSCs were able to give rise to offspring following transplantation, with transmission
through the germline to subsequent generations [7]. Using transplantation of premeiotic
female PGCs Zhang et al [24] further provided proof of principle that the adult ovary is able
to support oogenesis. Tilly’s group subsequently showed that following extensive doxyrubin-
induced loss, follicle numbers recover within 36 h. Reasoning that the small numbers of
presumed GSCs they had previously identified in the adult ovary would not be sufficient to
support this rapid recovery, they transplanted bone marrow from mice expressing GFP under
the Oct 4 promoter into germ cell-deficient Atm-/-mice and identified GFP-labelled primordial
follicles [25]. They concluded that a subpopulation of circulating bone marrow stem cells that
express PGC marker genes are responsible for the observed oocyte replenishment.
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Putative GSCs have been identified by co-labelling with proliferative and germ cell markers
and described either as small cells within the ovarian cortex [6,26-28] or clusters of cells which
also include somatic cells [29]. Other studies supported the discovery of ovarian GSCs [26,30]
but the considerable differences in marker expression, in vitro phenotype and differentiation
potential observed between these studies make the case somewhat controversial. In addition,
other groups have failed to repeat these findings and challenged their validity [24,31,32]. Kerr
et al described the expulsion of oocytes through the OSE into the peritoneum during the post-
natal phase of oocyte reduction, which could potentially be interpreted as GSCs [32]. By using
tamoxifen-induced random labelling of cells, Lei and Spradling traced the numbers of follicles
over time and argue that the follicle pool is in fact highly stable with a half-life of 10 – 11 months,
which would make the follicle pool at birth large enough to support the ~500 ovulations
required during the life time of a mouse [33]. They also failed to observe the generation of new
follicles even after depletion with busulphan toxin, thus putting into question that there is in
fact a need to explain regeneration of follicle numbers, a finding that is further supported by
mathematical modelling [34]. Similarly other groups, failed to observe replenishment of the
follicle pool by donor bone marrow-derived cells [35] or after chemical depletion [36].
It has been argued that some of these contradicting findings could be explained by the use of
Ddx4 –which was previously thought to be a cytoplasmic germ cell marker, but was used by
Zou et al [7] and White et al [8] to isolate cells based on their finding that the protein also
contains a transmembrane domain in GSCs. They suggest that the reason many other labora‐
tories have failed to identify GSCs in ovaries using Ddx4 [24] is due to the fact that cytoplasmic
Ddx4 expression in oocytes masks the presence of rare GSCs. Similarly, SSEA-1, which was
used by Johnson's group to identify ovarian GSCs [25], was reported by Bristol-Gould et al [34]
to overlap only with cells from the HSC lineage. Widespread acceptance of adult ovarian GSCs
will no doubt depend on the identification of a marker signature or more robust methods which
allows identification of these cells by all laboratories with the relevant expertise.
The difficulty in pinpointing putative ovarian GSCs or their niche in vivo, while at the same
time apparently being expandable and giving rise to the appropriate differentiated tissue in
vitro, mirrors the experience for stem cells of somatic adult tissues, as we shall explore below.
However, the unique properties and complex embryonic development of germ cells do in fact
give rise to some important differences.
In the current model, primordial germ cells (PGCs) derive from a small number of epiblast
cells which are specified before differentiation into the different germ layers begins. PGCs
subsequently undergo a complex migration through the allantois, along the developing
hindgut, finally entering the dorsal mesentery and the developing gonads. Despite the obvious
importance of these early developmental processes for future fertility, they remain little
understood. Mikedis and Downs have suggested that PGCs temporarily reside in an “allantoic
core domain” (ACD) which they propose has similar functions to the Spemann organiser,
consisting of a stem cell pool which extends the body axis in a posterior direction – contributing
not only to the germ cell lineage but also the three germ layers – effectively creating a strong
interface between the future umbilical cord and the developing embryo [37]. The stem cells in
the ACD express Oct4, Blimp1, Stella and Fragilis – markers thought to be specific for PGCs –
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but appear to contribute also to other tissues [38]. These observations, as well as the fact that
hematopoietic stem cells also migrate from the proximal epiblast to the embryonic aorta-
gonad-mesonephric region during the same period of development, imply that it is theoreti‐
cally possible that there may be “intermixing” or indeed that there is a common precursor pool
for PGCs and a subpopulation of bone marrow stem cells.
While a lineage tree analysis [39] based on somatic mutations accumulating in microsatellites
found that oocytes form a cluster which is entirely distinct from other cell populations –
suggesting that there is no intermixing of the germ cell precursor pool with that of any other
cell type – it is conceivable that a very rare subpopulation of bone marrow stem cells would
be missed in such an analysis. In fact their results also show that the number of mitotic divisions
oocytes have undergone increases with age and following unilateral ovarectomy. This may be
explained by recruitment of oocytes in the order in which they first differentiated during
development – but is also consistent with the notion of continuous oocyte production from
cycling stem cells. Many observers have suggested that if GSCs do exist, they are most likely
to be derived from the normal developmental precursors of oocytes, i.e. PGCs or oogonia –
which have not yet differentiated into oocytes and are still able to undergo mitosis [40-42]. The
close relationship of PGCs to pluripotent cells is demonstrated by the fact that following
isolation from the embryo, they can be converted back to a pluripotent phenotype termed
embryonic germ cells in vitro without genetic manipulation [43-45].
Even if one accepts the existence of GSCs, there are a number of unanswered questions apart
from their exact location. Firstly, it is not clear whether they contribute to oocyte production
under normal physiological conditions, or only after injury. Secondly, if the follicle pool is
replenished by GSCs, why does this replenishment eventually cease, leading to menopause?
Niikura et al [27] have suggested that the aging niche environment itself may be responsible
– however, the life-long production of spermatozoa in the testis indicates that this is not in
itself a sufficient explanation. A large number of germ cells in neonatal mouse ovaries have
not yet entered meiosis and can be induced to proliferate, increasing the follicular pool – but
by the time animals enter reproductive age the numbers have returned to “normal” levels [46].
This suggests that mechanisms exist within the ovary to actively regulate the number of
follicles. Together with the fact that a large proportion of oocytes are eliminated shortly after
birth [47] this indicates a highly selective process to ensure the removal of oocytes with reduced
meiotic fitness, which runs counter to the idea of continued oocyte replenishment from cycling
precursors.
Whether or not GSCs exist in vivo, the presence of cells that can be expanded and differentiated
to functioning oocytes in vitro – as suggested by Zou et al [7] and others [28] – would in itself
be of huge potential benefit for the treatment of infertility. Nonetheless, the long time required
to induce proliferation of these cells in vitro (around 10 weeks), compared to other adult stem
cells, suggests that transformation of the cells in vitro may be responsible for the observed
phenotype – similar to findings which describe the production of oocytes from other somatic
stem cells in vitro – or that indeed the results may be explained by rare primordial oocytes that
are carried over during the in vitro period.
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4. Uterine endometrial stem cells
From the volume of work, it is fair to say that human endometrium has been the most
intensively studied portion of the female genital tract in the field of adult stem cell research.
This is partly due to the fact that the uterus is by far the most accessible portion of the tract,
where sample collection and analysis is much less invasive compared to investigating ovary
or fallopian tubes, and partly to the logic assumption that such intensely proliferating and
renewing tissue should contain a stem cell pool. Since the stratum basalis of the endometrium
is necessary for monthly renewal of the functional layer [48], characterized by intense prolif‐
eration under stimulation of rising estradiol levels, it is a prime candidate for harboring stem
cells. Still, there is no common agreement yet where adult endometrial stem cells reside in
vivo. LRCs were first identified by BrdU labeling in the epithelial layer and underlying stroma
in postnatal mice [2]. However, by 12 weeks post labeling, no BrdU positive cells were left.
Suboptimal timing of the pulse could mean that division of slow-cycling stem cells was missed
such that only transitory amplifying progeny was labeled. Nevertheless, the study provided
the first in vivo evidence for the existence of long-lived cells in the endometrium.
A significant advance over BrdU labeling for localizing stem cells in the mouse was recently
achieved with the development of a histone2B-GFP (H2B-GFP) reporter in a Tet-inducible
system, in which a doxyclicline pulse leads to fluorescent labeling of chromosomes, without
mutagenic stress. This method allows induction of the construct during embryonic develop‐
ment, which increases the likelihood that stem cells will be labeled. With each cell division the
GFP signal is reduced until after ~ 12 weeks it can only be detected in LRCs. In the first study
using this system [49], the doxycyclin pulse was administred in adult animals and 12 weeks
after pulse withdrawal LRCs were identified only in the distal oviduct segment of fimbrium
and ampulla. Their presence was stable even after 47 weeks. In a follow-up study, labeling
was extended to the embryonic period, confirming localization of LRCs to the distal oviduct,
and identifying an additional population at the endocervical transition region but not within
the endometrium. Only a pulse during the pre-pubertal period (post natal day 21-42) resulted
in labeling rare cells in the glandular endometrial epithelium [4]. It is perhaps due to these
experimental difficulties in identifying the adult stem cells in the uterus of a living organism,
despite the undisputedly enormous capacity for endometrial regeneration and plasticity, that
alternative models have been proposed to explain regenerative capacity of the endometrium.
An interesting hypothesis that has gained some traction within the scientific community is the
possibility that bone marrow could be a source of endometrial stem cells. Previously, bone
marrow stem cells were reported to be able to differentiate into a wide variety of cell types
[50-52]. Analysis of bone marrow transplant recipients revealed the presence of donor cells in
the opening of endometrial glands, raising the possibility that a stem cell pool outside of the
reproductive system may contribute to the regeneration processes [53,54], mirroring the
findings with female GSCs. Ikoma and colleagues used in situ hybridization to confirm the
localization of Y chromosome-positive donor cells in the endometrium of a female patient who
had undergone bone marrow transplant from a male donor [55]. However newer studies have
questioned the functional importance of such findings, as bone marrow cells residing within
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the endometrium do not appear to contribute to the stem cell pool, which exhibits high
clonogenic capacity in vitro, but are instead reminiscent of terminally differentiated cells [56],
which could be explained by the capacity of bone marrow-derived cells to fuse with differen‐
tiated cells from a variety of organs [57].
Regardless of the difficulties in identifying and characterizing the adult stem cell niche in
the  intact  epithelium  in  vivo,  numerous  studies  in  recent  years  have  isolated  distinct
populations of putative adult stem or progenitor cells from uterine tissue and demonstrat‐
ed their  proliferative capacity and broad differentiation potential  in vitro.  Two different
classes  of  adult  stem cells  are  found in  the  endometrium:  mesenchymal  and epithelial.
Mesenchymal stem cells have also been named Endometrial Regenerative Cells (ERC) due
to their high proliferative potential. Although the ability to produce a clonal population of
cells  when  seeded  at  very  low  dilution  is  much  greater  for  the  stromal  mesenchymal
subpopulation, the epithelium also contains cells capable of clonal expansion in vitro. Self
renewal of endometrial stem cells in vitro was first demonstrated in pioneering work by
the group of Caroline Gargett [2,58,59]. In the absence of a widely accepted surface marker
for  endometrial  stem  cells,  they  demonstrated  that  multipotent  cells  can  be  efficiently
isolated based on the uptake of Hoechst 33342 [60]. The method of SP cells was original‐
ly established in procedures for adult stem cells isolation from the hematoopetic tissue [61].
It  made use of  the discovery that  the small  population of  adult  stem cells  in the tissue
differs from the differentiated cells by their capacity to efficiently eject Hoechst dye from
the  cytoplasm,  presumably  due  to  the  high  expression  of  the  ABCG2  transporter  [62].
Designated  endometrial  side  population  cells  (ESP),  consisting  of  both  epithelial  and
mesenchymal  SP  cells,  are  able  to  generate  endometrial  glandular  structures  in  vivo  if
transplanted  under  the  kidney  capsule  of  NOD/SCID  immunocompromised  mice  [63].
Interestingly, a fraction of the ESPs migrated and generated blood vessels to supply the
endometrium, showing potency to generate different types of tissue in the functional organ.
Still,  the  overall  efficiency  of  the  procedure  was  rather  low as  endometrium formation
occurred in only 2 out of 24 injected animals. Dramatic improvements in the outcome of
this type of xenograft was achieved by expanding and cloning lines of SP cells from both
epithelial and stromal compartments. Transplantation of individual lines supported by the
administration of estrogen (E2) and progesterone (P) to mimic the menstrual cycle gave rise
to  endometrial  tissue  in  all  animals  [56].  This  is  a  particularly  significant  finding  since
endometrial  stem  cells  do  not  express  E2  and  P  receptors.  Nevertheless,  the  hormonal
environment greatly affects the outcome of the tissue regeneration process. This phenomen‐
on  was  closely  analyzed  by  Janzen  and  colleagues  [64],  who  showed  that  hormonal
withdrawal in the xenograft mouse model leads to a pronounced decrease in the size of
endometrial tissue while the remaining cells are highly enriched in stem cells. This suggests
that the stem cell niche is activated at the beginning of each cycle, when both estradiol and
progesterone levels are low, while the subsequent hormonal stimulation drives regenera‐
tion  and  proliferation  of  transitory  amplifying  cells  up  to  their  final  differentiation  in
response  to  progesterone  stimulation  from  the  corpus  luteum  in  the  second  phase  of
menstrual  cycle.  On  the  molecular  level,  endometrial  stem  cells  showed  elevated  Wnt
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signaling activity and increased expression of the Wnt target genes Axin2, Cyclin D1, ID2,
CD44.
As well as studying the role of endometrial stem cells in regeneration of the functional
endometrium, a number of methods have been developed to use endometrial progenitors in
translational approaches for therapeutic purposes. In vitro differentiation assays suggest that
mesenchymal stromal stem cells may be able to differentiate into diverse cell types [58,65,66],
and can be efficiently isolated from menstrual blood. A clinical trial of endometrial stem cells
as a source of autologous regenerative cardiomyocytes to treat ischemic cardiac injury is
underway [67] and promising results were also reported for pancreatic island replacement in
a xenograft diabetic mouse model [68].
In parallel to the translational approaches, we need to get a better understanding of the
biology  of  endometrial  stem  cells  in  vivo  to  understand  how  these  cells  influence  the
development of pathologies in the uterus. There are strong indications that deregulation of
the stem cell niche plays a role in endometriosis, a disease which affects up to 10% of all
women and is present in nearly half of those experiencing fertility problems or pelvic pain
after the age of 35 [69]. The hallmark of endometriosis is the presence of ectopic explants
of endometrial tissue outside of the uterus, which can affect the fallopian tubes, the ovary
but also more distant regions of the pelvic cavity, causing pain and discomfort. Endometri‐
otic lesions have identical responses to hormonal stimuli as the endometrium of the uterus.
The model of “retrograde menstruation” is accepted as the most plausible explanation for
the  spread  of  endometriosis  tissue  through  the  genital  tract,  but  the  molecular  mecha‐
nisms which trigger and control the disease remain obscure. Analysis of menstrual tissue
samples from affected women showed that endometriosis patients have significantly more
fragments of the basalis layer in the flow than healthy controls [70]. Cells from menstrual
blood of patients also have longer than average telomeres, which is in agreement with an
enhanced stem cell presence [71]. According to this model, long-lived stem cells from the
basalis are disseminated and give rise to endometriotic lesions. In healthy women, on the
other hand, only the upper layer of the endometrium is ablated, leaving the basalis layer
intact. These data offer hope that characterization of the endometrial stem cell niche and
its  regulatory  mechanisms  will  lead  to  a  breakthrough  in  prevention  and  treatment  of
endometriosis – a disease that poses an enormous burden for patients’  quality of life as
well as high costs for the healthcare system.
5. Fallopian tube stem cells
Our understanding of the biology of fallopian tube epithelium is still rudimentary. From the
perspective of medical diagnostics, it is the least accessible portion of the female reproductive
tract. The fallopian tube is barely visible by ultrasound and even exploratory laparoscopy
offers only information about tubal patency, and no insight into the condition of the mucosa.
Current knowledge about tubal histology and pathology comes solely from patients of
salpingectomy procedures, where tubes are surgically removed, usually as part of a total
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hysterectomy. The importance of making progress in this area has been highlighted in recent
years, as the potential significance of this tissue in disease initiation has become clear. The
distal portion of the tubal fimbrium, and the ampulla with its abundant mucosal folds, are of
critical importance for oocyte capture and fertilization. Intimate contact of the fimbrium with
the surface of the ovary exposes the epithelial layer of the tube to the inflammatory signals
associated with ovulation which are present in follicular fluid. Thus, there is an increased
requirement for robust renewal mechanisms. Indeed, in vitro experiments with cell isolates
from the fallopian tube have defined a population that is positive for CD44 and integrin α6
and has the capacity for clonal growth, self renewal and differentiation into the secretory and
ciliated cells found in the tubal epithelial monolayer-specifically in the distal region of the tube
[72]. Strong clonogenic potential of a H2B-GFP-retaining subset of epithelial cells in the distal
oviduct and their capacity to form and maintain spheroids in vitro long-term has been
demonstrated in a mouse model [49]. These spheroids are able to differentiate into more
complex structures of the mucosa, strongly suggesting that they do indeed contain progenitor
cells of the tube with the potential to proliferate and differentiate in vitro. However, the exact
organization of the fallopian tube stem cell niche in vivo remains unknown apart from the
positive identification of candidate cells in label-retaining experiments in vivo mentioned
above. Moreover, the exact turnover rate of the epithelium and how it responds to different
physiological and environmental stimuli or stresses is yet to be established.
Beyond the requirement for Wnt signaling for normal development of the genital tract, several
studies have reported changes in Wnt signaling associated with pathology of the fallopian
tube. For example, activation of β-catenin signaling is implicated as a contributing factor in
ectopic pregnancy [73,74] and endometriosis [75]. Increased Wnt signaling is a mucosal
response to infection [76], confirming that this paracrine pathway plays a role in homeostasis
inside the fallopian tube. More studies are needed, however, to illuminate all aspects of
paracrine signaling in the fallopian tube epithelium in health and disease. As mentioned above,
Wnt signaling alterations are one of the hallmarks of ovarian cancer. Since there is now
consensus in the medical community, based on cumulative molecular and clinical evidence,
that a significant portion of high grade serous ovarian carcinoma originates from the fallopian
tube fimbrium rather than the ovarian surface epithelium, it has become imperative to
illuminate the regulatory mechanisms involved in fallopian tube epithelium homeostasis.
Different models of ovarian carcinogenesis and the potential role of adult stem cells in this
process will be reviewed fully later in this chapter.
6. Ovarian and cervical stem cells
In contrast to the uterus, direct evidence for adult stem cells in the ovary is sparse. However,
the tissue remodeling processes involved in ovulation require a considerable regeneration
potential within this organ that has to be maintained for several decades. Beyond the healing
of the ovulatory wound created in the epithelial surface during follicle rupture, ovarian
epithelial cells also undergo proliferation at the beginning of the menstrual cycle [77].
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Label-retaining cells on the ovarian surface were identified in vivo by comparing a histone-
GFP inducible transgenic model and BrdU labeling of animals [78]. It is important to note that
both methods resulted in identification of positive cells in the OSE epithelium of the ovary but
the two populations overlapped only in a minority of cases. This further underscores the
complexity and difficulty of identifying adult stem cells solely on the basis of cell division rate.
Recently, the ovarian surface was subjected to a more detailed analysis, and the highest
proportion of LRCs was detected in the hilum region close to the fallopian tube. These cells
expressed high levels of aldehyde dehydrogenase 1 (ALDH1), and were able to proliferate
long-term in vitro [3], forming spheres. Long-term pulse experiments and staining with the
proliferation marker Ki67 also suggested that slow-cycling cells are activated in a cyclical
fashion during the estrus phase, which supports a repair mechanism for the damaged OSE
monolayer. Finally, genetic lineage tracing of Lgr5 expression in the ovary was performed [3],
by using the Lgr5tm1(cre/ERT2)Cle/J mouse which harbors a genetic construct that enables GFP
labeling of Lgr5 expressing cells and tamoxifen-inducible expression of Cre recombinase.
When crossed with a strain harboring a stop codon in a dTomato sequence that can be excised
by Cre recombinase, offspring mice are produced in which easy tracing of the progeny of Lgr5-
expressing cells is possible by a simple tamoxifen pulse at the desired time point [79]. This
experiment revealed an Lgr5+ population at the hilum, which contributes to the whole OSE
monolayer during renewal of the epithelium in the course of 1 month [3]. Notably, this study
was focused on the ovary and no lineage tracing was analyzed in other portions of the genital
tract. A similar approach, with the SOX2 gene promoter controlling expression of CRE
recombinase in a tamoxifen-inducible fashion, revealed the existence of long-term lineage
labeling in the cervical epithelium of mice (Arnold et al 2012). It remains unclear, however, if
other parts of the female genital system contain epithelial cells originating from SOX2+
progenitors and it will be interesting to find out how these populations of putative stem cell
candidates identified by independent methods correlate with each other. It is of course feasible
that different tissue compartments harbor stem cells which are defined by different molecular
markers. Although these two studies represent a methodological breakthrough in the detection
of adult stem cells, by demonstrating the in vivo capacity of these cells to give rise to differ‐
entiated progeny in the tissue through tracing cellular markers in physiological conditions,
they are not entirely comprehensive. This approach is hypothesis-driven by selecting candi‐
date genes; however, the list of potential stemness regulators that could be tested is much
longer. For example, Lgr5 is only one member of the Lgr receptor family, and other members
are also involved in regulating tissue regeneration, e.g. Lgr6 in the hair follicle [80] and Lgr4
in the prostate [81]. More detailed studies are needed to confirm whether the LGR5+ cells
detected in the hilum represent the pool of true stem cells or a more dynamic population of
amplifying cells that have already undergone a degree of lineage commitment. The SOX2+ cells
identified in the cervix are a good starting point to define the molecular characteristics of the
long-lived basal cells which have so far proven to be elusive using other tracing methods, and
this genetic system will provide a valuable tool for a more detailed analysis of the adult stem
cell niche in the future.
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7. Adult stem cells between development and disease — Role of the Wnt
pathway
The  precise  signaling  pathways  controlling  the  renewal  processes  of  the  fallopian  tube
epithelium,  endometrium and ovary  remain  unknown,  but  there  are  several  reasons  to
assume  that  they  depend  on  paracrine  Wnt,  Notch  and  BMP  signaling.  Wnt  signaling
controls crucial developmental processes during all phases of embryogenesis and during
adult life. Wnt ligands interact with a family of receptors, inducing a variety of responses
depending on the cellular context. The main transducer of Wnt signalling within the cell
is β-catenin, which translocates to the nucleus and induces expression of target genes via
several transcription factors (Figure 2).
Although a detailed overview of Wnt signaling is beyond the scope of this chapter, we will
briefly outline its involvement in the control of the cell behavior within a tissue, affecting,
among other processes, proliferation, establishment of polarity, differentiation, morphoge‐
netic movements and apoptosis. With respect to tissue homeostasis, Wnt signaling acts as a
key cell-cell communication network during tissue formation in development, as well as for
maintaining tissue function. The embryological development of the female genital tract relies
on active Wnt signaling, as evidenced by Müllerian aplasia. This autosomal mutation in the
Wnt4 gene leads to a severely underdeveloped or absent uterus. Mouse models have further
revealed a strong dependence of developmental processes on Wnt 5a, 7a, and 9b, since mutant
animals showed severe malformations of different parts of the genital tract raging from
defective coiling of oviducts to absence of the upper vagina or uterine glands [82-84]. The
importance of the Wnt pathway for maintenance of homeostasis is well-documented by
molecular and genetic analysis of numerous human malignancies. Perhaps the most startling
example of the tight relationship between Wnt signaling and control of proliferation in mucosal
epithelium is provided by the relationship between Adenomatous polyposis coli (APC)
mutations and colon cancer. APC protein in complex with Axin1 promotes degradation of β-
catenin and thereby inhibits Wnt signaling transduction (see Fig 2). In familial adenomatous
polyposis patients, who carry an APC functional deletion mutation, the risk of developing
colon cancer is almost 100% and 5% of sporadic colon cancer patients harbor either APC loss-
of-function or β-catenin activating mutations [85]. Mutations in components of the Wnt
pathway are frequently found in numerous other malignancies as well, e.g. pancreas, liver,
kidney, pituitary, and notably also in the ovary and endometrium [86].
Although the significance of Wnt signaling for tissue maintenance has been known for the last
couple of decades, it is the discovery of adult tissue stem cells which led to a breakthrough in
our understanding of the regulatory mechanisms at the molecular level. Lgr5-expressing stem
cells of the intestine ensure renewal of the mucosa every 3-5 days. Although Lgr5+ cells at the
base of intestinal crypts are sufficient to recreate the complete epithelial layer in vitro, an
alternative model attributes true “stemness” to rare, more quiescent cells in the wall of the
crypt, which express Bmi1, HOPX and mTERT [87-89]. Ablation of Lgr5+ cells does not disrupt
homeostasis, as Bmi1+ cells compensate for the loss [90]. This illustrates the complexity of the
regulatory stem cell niche, where different cells can be recruited and even reprogrammed,
Adult Stem Cell Niches152
depending on the conditions during epithelial renewal. Although Lgr5 is a Wnt signaling
target, crypt organization, cell fate determination and differentiation are also dependent on
integration of signals from the Notch [91] and TGF-β pathways. Such paracrine signaling
pathways have emerged as a common principle of functioning stem cell niches in other organs
[92-95]. The inherent longevity of adult stem is a potent mechanism for dissemination of
accumulated mutations within the tissue.
Figure 2. Paracrine regulation of the adult stem cell niche. A) Schematic representation of the cellular mechanism of
β-catenin turnover in the cytoplasm. After the Wnt signal triggers dimerization of receptors, β-catenin is released from
the degradation complex and translocates to the nucleus, where it activates Wnt target genes; B) Hierarchical organi‐
zation of the intestinal crypt, with Lgr5+stem cells localizing to the bottom off the crypt between nurturing Paneth
cells. Above the stem cells, there is a zone of intense proliferation (transitory amplifying cells), followed by terminally
differentiated epithelium, which has short life span (1-2 days)
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8. Cancer stem cells and the putative link to adult stem cells
Parallel to the discovery of adult stem cells in healthy tissues, cancer research has produced a
bulk of evidence showing that most malignancies are not homogenous cell masses but rather
heterogeneous tissues whose progression depends on the fitness of a distinct cellular fraction:
cancer stem cells (CSCs). CSCs can confer resistance to chemotherapeutic agents or exhibit
other characteristics that provide a competitive advantage to the cancer and ensure its
progression [96-99]. In many cases, long-term prognosis and patient survival can be correlated
with the frequency of cancer stem cells in the tumor at the time of diagnosis [100]. CSCs exhibit
the characteristics of adult stem cells: self renewal and differentiation capacity. They can be
distinguished from the bulk of the tumor tissue as the only fraction that is able to generate new
tumors when transplanted into immunocompromised mice [101,102]. For this reason, they are
sometimes referred to as tumor initiating cells. This property of cancer stem cells has been
demonstrated for numerous malignancies, including ovarian and endometrial cancer. As with
markers of adult stem cells, markers specifically associated with cancer stem cells are also
proving difficult to identify. It is of course possible that there is no unique cancer stem cell for
ovarian, endometrial or other genital malignancies and that stemness can be achieved by
alternative routes in individual cases, thereby resulting in different combinations of surface
markers such as CD44, EpCAM, ALDH1, CD117, CD133 etc, which have been identified by
different studies [81,103,104]. Cancer stem cells are intermixed with the bulk of the tumor
tissue, but are found enriched in advanced stages of metastasis, in spheres present in effusions
recovered from ascites [105]. Spheres exhibit anchorage-independent growth but can efficient‐
ly adhere to mesothelial cells in the peritoneum via integrin 1, which may play a role in
metastatic spread. It is not yet known what triggers formation of spheres, although the
physiological implications for disease progression and response to treatment are immense.
The compact organization of the cells in a cluster makes drug delivery ineffective, either due
to the difficulty of drugs to penetrate, or induction of a quiescent state in cells at the core
through tight cell-cell contacts, making them insensitive to agents targeting actively replicating
cells. Either way, it is clear that 3D organization represents another layer of protection for
cancer cells from chemotherapy. This effect has been demonstrated by comparing the response
to the standard therapeutic drugs cisplatin and paclitaxel for 11 different ovarian cancer cell
lines in 2D in 3D [106].
Importantly, however, it remains unknown if and how cancer stem cells are related to normal
adult stem cells. Cancer stem cells may develop from adult stem cells by losing dependence
on niche regulatory factors, or they may simply be the progeny of differentiated cells that have
acquired "stemness" characteristics during the accumulation of mutations and cellular
transformation. It is conceivable that both mechanisms could occur in all or some types of
cancer. If there is indeed a causal relationship between dysregulation of the adult stem cell
niche and carcinogenesis, this may open up new possibilities for early diagnosis and timely
intervention. Since the research field of cancer stem cells is currently offering a variety of
sometimes competing models of what defines this population in endometrial, cervical and
serous ovarian cancer, we focus our attention on the current understanding of carcinogenesis
in the genital tract. Understanding of the cellular events that lead to initial transformation
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could prove to be of pivotal importance for resolving remaining questions about tumor spread
and the role of cancer stem cells. In this light, we will address changes in tissue architecture
and physiology of the female reproductive tract that could favor malignant transformation
and bring it into context of therapeutic implications, particularly in light of recent evidence
that dysregulation of tissue homeostasis could be the result of infection with certain sexually
transmitted pathogens.
Malignant tumors of the genital tract are the third leading cause of cancer related deaths after
breast cancer and lung cancer [107]. Based on the primary organ, affected cancers are classified
as ovarian, uterine, cervical, vulval and vaginal. The high prevalence of these cancers is likely
to be related to the great plasticity of these tissues, their regenerative potential and thus
probably their high cell turnover as well. On top of this, openness to the external environment
and exposure to pathogens makes them potentially vulnerable to the transformation. The latter
has been demonstrated by the dramatic correlation between HPV infection cervical cancers,
since nearly 100% of patients are HPV positive [108].
9. Serous ovarian cancer and stem cells of the fallopian tube
From the perspective of patient care and long-term prognosis, one of the biggest challenges
for medicine represents high grade serous ovarian cancer, an aggressive form of epithelial
ovarian cancer which has a survival rate of under 40 % after 10 years [109]. This deadly
malignancy takes more than 14,000 lives per year in the US alone and no improvement can be
expected in the foreseeable future, due to the absence of early screening methods and the
aggressive nature of the cancer. The origin of high-grade serous ovarian cancer (HG-SOC) has
puzzled medical doctors and pathologists for decades. Naturally, the site of carcinogenesis
was initially attributed to OSE cells [110]. Numerous examples of developmental genetics show
that relatively complex changes in phenotype are frequently induced by expression of only
one master regulator gene. In the case of OSE cells, ectopic expression of homeobox transcrip‐
tion factor HOX9 in the xenograft mouse model causes Müllerean metaplasia-transformation
of cuboidal to papillary columnar epithelium resembling fallopian tube mucosa and serous
ovarian cancer [111]. However, there is as yet no clinical evidence that this conversion also
occurs in vivo. The scarcity of precancerous lesions or early stage carcinoma in situ detected
by pathologies [112], raises questions whether this hypothesis is supported by clinical data. In
parallel, the hypothesis that the etiology of HG-SOC could be explained by malignant
transformation in neighboring tubal epithelium has gained increasing support. The fallopian
tube develops from the Müllerian duct tissue, encompassing a columnar epithelial monolayer,
which continues to express PAX8, the main cellular marker of “Müllerian differentiation" – a
phenotype which is reminiscent of cancer tissue from HG-SOC patients. A breakthrough came
from a cohort of clinical studies in BRCA mutation carriers, who have a very high hereditary
risk of developing ovarian and breast cancer later in life. Small malignancies within the tubal
epithelium (so-called serous tubal intraepithelial carcinoma – STIC) were discovered in up to
10% of patients who underwent prophylactic surgery to remove both fallopian tubes and
ovaries [113]. These apparently healthy patients thus already had cancer in their fallopian
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tubes, which had not yet metastasized to the ovary. Samples from HG-SOC patients subse‐
quently confirmed that STICS were present in up to 60% of cases [114]. Although not definitive
proof, these findings strongly support the hypothesis that the fallopian tube epithelium is the
tissue of origin of serous ovarian cancer. Recently, malignant transformation of the fallopian
epithelium into full-blown ovarian cancer has been successfully triggered in a transgenic
mouse model [115]. Here, the Cre recombinase system was used under control of the PAX8
promoter to introduce mutations into Brca1/2, Tp53 and Pten, which are frequently found
mutated in HG-SOC. The animals developed malignant disease with a HG-SOC phenotype,
which metastasized to the ovary, peritoneum or liver – modes of spread that are also found in
patients, and were for a long time considered as evidence for separate origins of the disease.
Regardless of the important function that BRCA1/2-mediated DNA repair mechanisms have
in fallopian tube cells, in order to solve the complex problem of HGSC etiology it is necessary
to understand the role of the p53 tumor suppressor. p53 is mutated in nearly all HG-SOC
patients, but somatic mutations of p53 on their own do not increase the likelihood of HGSC
development [116]. Nevertheless, nuclear accumulation of p53 is much more frequent in tubes
where STICs are also found, arguing that this phenotype is perhaps characteristic of a cellular
state which is prone to transformation upon further “hits”. However, a valid causal relation‐
ship between these cellular atypias and the appearance of fully transformed malignant serous
tubal intraepithelial carcinoma (STICs) is not yet conclusively proven. Therefore, true prema‐
lignant lesions in the fallopian tube as precursors of HG-SOC are yet to be defined.
An understanding of the molecular mechanisms of epithelial homeostasis and renewal in
healthy fallopian tube tissue is thus likely to be essential for successful resolution of the
molecular events that lead to serous ovarian cancer. Of particular interest in this context is how
slow-cycling adult stem cells in the distal fallopian tube respond to long-term changes in the
tissue microenvironment from numerous different stimuli such as inflammation, genotoxic
stress changes in extracellular matrix, or the presence of pathogens. The role of the microen‐
viroment via cooperation of different cellular compartments and extracellular matrix not only
provides conditions for physiologically regulated responses, such are repair and healing, but
can also decisively influence the progression of disease. As discussed in the section on cancer
stem cells, cancer tissue is heterogeneous and keeping in mind the monoclonal origin of
cancers, it is unclear whether differentiated cells are subject to transformation followed by
expansion, whether some of them are reprogrammed into cancer stem cells, or whether
deregulated stem cells are the source of the malignancy after additional somatic mutations.
The latter hypothesis is somewhat more likely, given the presence of cells with stem cell
characteristics in tumors, and that the alternative would mean acquisition of pluripotency.
However, at this stage reverse reprogramming of differentiated cells cannot be excluded as
the underlying mechanism.
The same is true for endometrial cancer. In contrast to the complete absence of diagnostic tools
for early detection of ovarian cancer, there is a detailed classification of neoplastic changes in
the endometrium – known as endometrial intraepithelial neoplasia (EIN), although there is a
lot of controversy among pathologists how reliable the existing methodology is as a prognostic
factor. Moreover, there is still no consensus regarding the cellular origin of the malignant
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tissue, or indeed the role played by adult stem cells. Approximately 75-80% of endometrial
cancers are classified as type 1-endometrioid endometrial cancer (EEC) – with the remaining
cases belonging to papillary, mucinous or clear cell types. Histologically, they consist of
malignant endometrial cells in the columnar monolayer, although squamous metaplasia is
sometimes observed [117]. They frequently harbor alterations in PTEN and Wnt signaling
pathways, and a prevalent staining pattern of nuclear catenin localization is found in up to
60% of endometrial hyperplasias and 30% of endometrial cancers [118]. In a mouse model with
constitutively active Wnt signaling due to APC deletion in the genital tract, loss of PTEN
function was found to be the rate-limiting step of carcinogenesis inside the uterus, while
activation of β-catenin signaling increased the severity of the disease [119]. Strikingly, a follow-
up study of the mice that were initially declared tumor free by inspection of the uterus revealed
that 62% did get sendometrioid cancer, but not in the uterus, as would be expected, but rather
in the neighboring distal oviduct [120]. Thus, this recent study argues that the fallopian tube
may participate not only in the carcinogenesis HG-SOC but also in a subset of endometrial
cancers. Notably, in human patients loss of PTEN associates with better prognosis and reduced
risk of metastasis, since the tumor appears more differentiated [121]. These at first sight
contradictory facts might be explained by the different requirements of cancer cells in the early
and late stages of progression. While PTEN is a tumor suppressor, its major downstream
effector, p-Akt, has dual functions in tumor cells. In mammary carcinoma, activated Akt
enhances carcinogenesis via the ErbB-2 pathway, but inhibits invasion of the tumor and its
metastasis [122]. Of course, mutations in the PTEN-PI3 kinase pathway components represent
only one of the important signaling routes that have been found to be altered in endometrial
cancer. Similarly, as in ovarian cancer, it remains to be seen how discrete cytological changes
progress into full-blown cancer and which cells give rise to the cancer stem cells that are
detected in the later stages of malignant disease. A recent study, based on a detailed analysis
of 113 cases of endometrial cancer, postulated an important role for SALL4 protein which is
known as a strong determinator of pluripotency in human embryonic cells [123]. The authors
found SALL4 expressed in 47% of cancer samples while no expression was detected either in
healthy controls or in the hyperplastic tissue, and increased levels of expression negatively
influenced prognosis and patient survival. SALL4 increases c-Myc transcriptional activity and
reduces the response of affected cells to carboplatin treatment. While it cannot be excluded
that SALL4 expression in precancerous stages is limited to very low levels in sparse stem cells
below detection limit of whole tissue sample, these results strongly indicate that pluripotent
capacity of the tumor is acquired at later stages of disease development. The existence of cells
with stem cell characteristics has recently also been demonstrated for cervical cancer. Sox2-
expressing cells constitute a small percentage of cells in cervical cancer cell lines, but they show
much greater tumor forming capacity in the xenograft mouse model than the remaining cells
[124]. This correlates well with findings of tracing experiments from the Sox2 mouse model
mentioned above, which identified stem cell lineages in the cervix [125]. It is becoming
increasingly clear that the basal layer of cervical epithelium plays a decisive role in the initiation
of cervical cancer, as these are the only dividing cells in squamous stratified epithelium. Active
progression of the cell cycle is a prerequisite for HPV-driven cellular transformation, as host
cells have to pass through the prophase of mitosis for transcription of viral genes to be initiated
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and infection established [126]. Cervical cancer develops from premalignant lesions called
cervical intraepithelial neoplasia (CIN), which are routinely detected by regular Pap smears.
Importantly, CINs occur almost exclusively within the transformation zone of the cervix, a
region of metaplastic conversion of columnar to squamous epithelium. Regular screening has
greatly improved the long-term prognosis and survival rates of cervical cancer [127].
The mounting evidence for an involvement of the fallopian tube in development of ovarian
and potentially other cancers thus highlights the importance of developing methodologies to
improve diagnostic sampling and visualization of this organ. In particular, there is an imper‐
ative to improve diagnostics of the tube in patients. Ideally, some kind of endoscopy would
enable detailed exploration of the mucosa in vivo, including the taking of biopsies. This would
improve our understanding of phenotypical changes that take place in the epithelium, better
define and categorize alterations and discover real premalignant lesions or early malignancies.
The result would hopefully be comparable to the advancement that routine colonoscopy
brought to early diagnosis and proper management of colon cancer.
10. Conclusion
We have presented in detail the current "state of the art" in the field of adult stem cells of the
female reproductive system, their role in maintaining healthy mucosal tissue and changes that
occur during disease. Moreover, we have focused on the phenomenon of cancer stem cells,
which appears to be very important for the progression of malignancies by giving tumor tissue
a competitive advantage. Still, the question remains how adult stem cells relate to cancer stem
cells, and the models which have been postulated so far, as in the case of cervical cancer, have
yet to be experimentally proven.
Regardless of the final outcome, it is almost certain that adult stem cells play an important role
in the process of cancer initiation. Carcinogenesis is considered to be a long, stepwise process
of accumulation of mutations. Therefore, differentiated cells with short life spans are unlikely
to pass on mutations unless the initial acquired change leads to immortalization. Adult stem
cells on the other hand, are long-lived and thereby inevitably accumulate mutations over
decades. With each asymmetric division, mutations are passed to the differentiating progeny.
The final "transformation step" may occur afterwards in the differentiated cell, or the stem cell
itself may reach the stage where it becomes cancerous. The latter model presumes that as tumor
tissue grows, the stem cell continues to give rise to differentiated progeny, while becoming
itself a cancer stem cell. In both cases, a definitive premalignant molecular fingerprint should
be found in the original adult stem cell. Therefore, it will be of great importance to further
characterize adult stem cells in the ovary, fallopian tube and uterus and elucidate the molecular
mechanisms of epithelial renewal in healthy tissue, but also to determine the genomic changes
which occur over time in response to altered hormonal stimulation, tissue injury or infection.
Recent studies with novel genetic lineage tracing tools in the mouse give a promising outlook
that concrete molecular pathways controlling stemness will be defined in the near future. Only
when this goal has been achieved is it conceivable that a major breakthrough in the early
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treatment and diagnosis of female reproductive cancers and endometriosis can be achieved.
As we have outlined, the high activity of adult stem cells in the female reproductive tract that
is required to maintain cyclical changes in tissue architecture put these tissues at a particularly
high risk for accumulating mutations with the potential for transformation. This is likely to be
exacerbated by the fact that the genital system is exposed to a variety of sexually transmitted
pathogens. There is mounting evidence that these infections may play a role in initiation of
malignancies in the ovary, uterus or as co-factors to HPV in the cervix [18-20]. Although
deciphering the behavior of adult stem cells in disease remains a very challenging research
area, a dynamic field of translational approaches has emerged, using stem cells as a source of
healthy tissue in different models of in vitro differentiation and transplantation. There is
justified optimism that such models will help to elucidate not only the events involved in de-
regulation of the adult stem cell niche, but also the interaction of human pathogens with this
niche, as well as the somatic tissue derived from it. A more complete understanding of these
events will provide a basis for the development of more effective preventative and therapeutic
measures for diseases of the female reproductive tract.
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